Permalink
Cannot retrieve contributors at this time
Join GitHub today
GitHub is home to over 36 million developers working together to host and review code, manage projects, and build software together.
Sign up
Fetching contributors…
![](https://scholarlyorphans.org/memento/20200720134642im_/https://github.githubassets.com/images/spinners/octocat-spinner-32-EAF2F5.gif)
{ | |
"translatorID": "ba10b5bc-562f-11e1-b20d-a3084924019b", | |
"label": "Nuclear Receptor Signaling", | |
"creator": "Aurimas Vinckevicius", | |
"target": "^https?://[^/]*nursa\\.org/(article|nrs|abstract)", | |
"minVersion": "3.0", | |
"maxVersion": "", | |
"priority": 100, | |
"inRepository": true, | |
"translatorType": 4, | |
"browserSupport": "gcsibv", | |
"lastUpdated": "2014-03-03 22:02:54" | |
} | |
/* | |
Nuclear Receptor Signaling Translator | |
Copyright (C) 2012 Aurimas Vinckevicius | |
This program is free software: you can redistribute it and/or modify | |
it under the terms of the GNU Affero General Public License as published by | |
the Free Software Foundation, either version 3 of the License, or | |
(at your option) any later version. | |
This program is distributed in the hope that it will be useful, | |
but WITHOUT ANY WARRANTY; without even the implied warranty of | |
MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the | |
GNU Affero General Public License for more details. | |
You should have received a copy of the GNU Affero General Public License | |
along with this program. If not, see <http://www.gnu.org/licenses/>. | |
*/ | |
/* | |
Translator for Nuclear Receptor Signaling journal. Example URLs: | |
Multiple: | |
http://www.nursa.org/nrs.cfm?detail=Perspectives&journalVolume=9 | |
http://www.nursa.org/nrs.cfm?detail=Reviews&journalVolume=9 | |
http://www.nursa.org/nrs.cfm?detail=Most%20Viewed&journalVolume=9 | |
http://www.nursa.org/nrs.cfm?detail=Methods&journalVolume=9 | |
Journal Article: | |
http://www.nursa.org/abstract.cfm?doi=10.1621/nrs.07008 | |
http://www.nursa.org/article.cfm?doi=10.1621/nrs.09001 | |
*/ | |
function relativeToAbsolute(doc, url) { | |
if ( typeof(url) == 'undefined' || url.length < 1 ) { | |
return doc.location.toString(); | |
} | |
//check whether it's not already absolute | |
if (url.match(/^\w+:\/\//)) { | |
return url; | |
} | |
if (url.indexOf('/') == 0) { | |
//relative to root | |
return doc.location.protocol + '//' + doc.location.host + | |
( (doc.location.port.length)?':' + doc.location.port:'' ) + | |
url; | |
} else { | |
//relative to current directory | |
var location = doc.location.toString(); | |
if ( location.indexOf('?') > -1 ) { | |
location = location.slice(0, location.indexOf('?')); | |
} | |
return location.replace(/([^\/]\/)[^\/]+$/,'$1') + url; | |
} | |
} | |
function detectWeb(doc, url) { | |
if ( url.match('nrs.cfm') && | |
url.match(/detail=(perspectives|reviews|most%20viewed|methods)(&|$)/i) ) { | |
return 'multiple'; | |
} else if ( !doc.title.match(/^Error/i) && | |
doc.title.trim().toLowerCase() != 'nursa |' ) { | |
return 'journalArticle'; | |
} | |
} | |
function doWeb(doc, url) { | |
var namespace = doc.documentElement.namespaceURI; | |
var nsResolver = namespace ? function(prefix) { | |
if (prefix == 'x') return namespace; else return null; | |
} : null; | |
if ( detectWeb(doc, url) == 'multiple' ) { | |
var items = Zotero.Utilities.xpath(doc, '//div[@class="articleItemFull"]'); | |
var title, itemUrl; | |
var selectFrom = new Object(); | |
for ( var i in items ) { | |
title = Zotero.Utilities.xpathText(items[i], './i[text()="Nucl Recept Signal"]/preceding-sibling::node()', null, ' '); | |
itemUrl = Zotero.Utilities.xpath(items[i], './a[text()="Full Text"]').shift(); | |
if (title && itemUrl) { | |
title = Zotero.Utilities.trimInternal( title.slice(title.indexOf(')')+1).trim() ); | |
selectFrom[relativeToAbsolute(doc, itemUrl.href)] = title; | |
} | |
} | |
Zotero.selectItems(selectFrom, | |
function(selectedItems) { | |
if ( selectedItems == null ) return true; | |
var urls = new Array(); | |
for ( var item in selectedItems ) { | |
urls.push(item); | |
} | |
Zotero.Utilities.processDocuments(urls, | |
function(newDoc) { | |
doWeb(newDoc, newDoc.location.href) | |
}, | |
function() { Zotero.done(); }); | |
}); | |
} else { | |
//load full text instead of abstract to get the full auhor names | |
if ( url.match('abstract.cfm') ) { | |
Zotero.Utilities.processDocuments(url.replace(/abstract.cfm/,'article.cfm'), | |
function(newDoc) { | |
doWeb(newDoc, newDoc.location.href) | |
}, | |
function() { Zotero.done(); }); | |
return null; | |
} | |
var item = new Zotero.Item('journalArticle'); | |
item.title = Zotero.Utilities.xpathText(doc, '//div[contains(@class,"articleTitle")]').trim(); | |
var authors = doc.evaluate('//div[@class="topAuthors"]//span', doc, nsResolver, XPathResult.ANY_TYPE, null); | |
var author; | |
while ( author = authors.iterateNext() ) { | |
author = author.textContent.trim().replace(/\s+and$/,''); | |
item.creators.push( Zotero.Utilities.cleanAuthor(author, 'author', false) ); | |
} | |
item.publicationTitle = 'Nuclear Receptor Signaling'; | |
item.journalAbbreviation = 'Nucl. Recept. Signaling'; | |
var published = Zotero.Utilities.xpathText(doc, '//div[contains(@class,"bottomHeader")]/p[1]').trim(); | |
var pubDelim = 'Published:'; | |
if ( published && published.indexOf(pubDelim) != -1 ) { | |
item.date = published.slice( published.lastIndexOf(pubDelim) + pubDelim.length ).trim(); | |
} | |
item.volume = Zotero.Utilities.xpathText(doc, '//div[contains(@class,"volumeCiteInfo")][2]/b'); | |
var page = Zotero.Utilities.xpathText(doc, '//div[contains(@class,"volumeCiteInfo")][2]/text()[2]'); | |
if (page) { | |
item.pages = page.replace(/\W/g,''); | |
} | |
item.abstractNote = Zotero.Utilities.xpathText(doc, '//div[contains(@class,"abstract")]/p', null, "\n"); | |
var doi = Zotero.Utilities.xpathText(doc, '//div[contains(@class,"bottomHeader")]/p[3]/text()[normalize-space()]'); | |
if (doi) { | |
item.DOI = doi.trim(); | |
} | |
item.url = url; | |
item.ISSN = "1550-7629"; | |
var rights = Zotero.Utilities.xpathText(doc, '//div[contains(@class,"bottomHeader")]/p[2]'); | |
if (rights) { | |
item.rights = rights; | |
} | |
item.accessDate = 'CURRENT_TIMESTAMP'; | |
var pdfURL = Zotero.Utilities.xpath(doc, '//div[span/text() = "Download PDF"]/a').shift(); | |
if (pdfURL) { | |
item.attachments = [{ | |
url: relativeToAbsolute(doc, pdfURL.href), | |
title: 'Full Text PDF', | |
mimeType: 'application/pdf'}]; | |
} | |
item.complete(); | |
} | |
} | |
/** BEGIN TEST CASES **/ | |
var testCases = [ | |
{ | |
"type": "web", | |
"url": "http://www.nursa.org/article.cfm?doi=10.1621/nrs.09002", | |
"items": [ | |
{ | |
"itemType": "journalArticle", | |
"creators": [ | |
{ | |
"firstName": "Stephen", | |
"lastName": "Safe", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "Kyounghyun", | |
"lastName": "Kim", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "Xi", | |
"lastName": "Li", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "Syng-Ook", | |
"lastName": "Lee", | |
"creatorType": "author" | |
} | |
], | |
"notes": [], | |
"tags": [], | |
"seeAlso": [], | |
"attachments": [ | |
{ | |
"url": "http://www.nursa.org/retrieveFile.cfm?type=NRS&file=nrs09002.pdf", | |
"title": "Full Text PDF", | |
"mimeType": "application/pdf" | |
} | |
], | |
"title": "NR4A orphan receptors and cancer", | |
"publicationTitle": "Nuclear Receptor Signaling", | |
"journalAbbreviation": "Nucl. Recept. Signaling", | |
"date": "March 18, 2011", | |
"volume": "9", | |
"pages": "e002", | |
"abstractNote": "NR4A orphan receptors are members of the nuclear receptor (NR) superfamily of transcription factors and include NR4A1 (Nur77, TR3, NGFI-B), NR4A2 (Nurr1), and NR4A3 (Nor1). NR4A receptors are immediate-early genes induced by multiple stimuli and modulate gene expression by interacting as monomers or homodimers to NGFI-B response elements (NBREs) and Nur-responsive elements (NuREs), respectively. NR4A1 and NR4A2 (but not NR4A3) also form heterodimers with the retinoic acid X receptor (RXR) that bind a DR5 motif, and there is evidence that NR4A1 can activate or deactivate gene expression in cancer cells through interactions with DNA-bound specificity protein 1(Sp1) transcription factor. NR4A receptors play important roles in cellular homeostasis and disease, and there is increasing evidence that they exhibit pro-oncogenic activity in most tumors and thereby represent novel targets for chemotherapeutic drugs. Many apoptosis-inducing drugs induce nuclear export of NR4A1 and activate apoptosis in cancer cell lines through formation of extranuclear complexes including a pro-apoptotic mitochondrial NR4A1-bcl-2 complex. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methane analogs exhibit structure-dependent activation or deactivation of nuclear NR4A1 to induce apoptosis, whereas cytosporone B and structural analogs activate both nuclear and extranuclear NR4A1-dependent pro-apoptotic pathways. The roles of NR4A2 and NR4A3 in carcinogenesis are less well-defined; however, there is evidence suggesting that NR4A receptors are important targets for development of new mechanism-based anticancer drugs.", | |
"DOI": "10.1621/nrs.09002", | |
"url": "http://www.nursa.org/article.cfm?doi=10.1621/nrs.09002", | |
"ISSN": "1550-7629", | |
"rights": "Copyright © 2011, Safe et al. This is an open-access article distributed under the terms of the Creative Commons Non-Commercial Attribution License, which permits unrestricted non-commercial use distribution and reproduction in any medium, provided the original work is properly cited.", | |
"accessDate": "CURRENT_TIMESTAMP", | |
"libraryCatalog": "Nuclear Receptor Signaling" | |
} | |
] | |
} | |
] | |
/** END TEST CASES **/ |